Able Graig's Blog (2)

CD BioSciences recently announced the launch of its bio-layer interferometry (BLI) platform. This platform aims to accelerate biomolecular interaction analysis, allowing for more efficient drug discovery and development processes.

Bio-layer interferometry is a label-free, real-time, and high-throughput technique used for studying biomolecular interactions. It leverages the principle of bio-layer interferometry, where light waves interfere with each other to create an optical…

CD BioSciences, a leading provider of cutting-edge research and development solutions, has once again established its position as a reliable partner in the field of neuroscience research through its cutting-edge biophysical analysis techniques. The company's latest breakthroughs help revolutionize the way researchers study the intricate workings of the brain, enhancing the understanding…